These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9399903)

  • 21. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
    Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progression.
    Hendel H; Hénon N; Lebuanec H; Lachgar A; Poncelet H; Caillat-Zucman S; Winkler CA; Smith MW; Kenefic L; O'Brien S; Lu W; Andrieu JM; Zagury D; Schächter F; Rappaport J; Zagury JF
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):381-6. PubMed ID: 9833747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Distribution of HIV resistance CCR5-delta 32, CCR2-64 I and SDF1-3'A alleles and their polymorphisms in the Han population in China].
    Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Shi M; Jiang J; Wang Y; Zhang B; Liu M; Li Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):256-60. PubMed ID: 11860793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New CCR5 variants associated with reduced HIV coreceptor function in southeast Asia.
    Capoulade-Métay C; Ma L; Truong LX; Dudoit Y; Versmisse P; Nguyen NV; Nguyen M; Scott-Algara D; Barré-Sinoussi F; Debré P; Bismuth G; Pancino G; Theodorou I
    AIDS; 2004 Nov; 18(17):2243-52. PubMed ID: 15577536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The frequency of mutation in CCR5 gene among Koreans.
    Oh MD; Kim SS; Kim EY; Lee S; Kim N; Park KY; Kim U; Kim T; Kim T; Choe K; Lee JS
    Int J STD AIDS; 2000 Apr; 11(4):266-7. PubMed ID: 10772093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes.
    Stephens JC; Reich DE; Goldstein DB; Shin HD; Smith MW; Carrington M; Winkler C; Huttley GA; Allikmets R; Schriml L; Gerrard B; Malasky M; Ramos MD; Morlot S; Tzetis M; Oddoux C; di Giovine FS; Nasioulas G; Chandler D; Aseev M; Hanson M; Kalaydjieva L; Glavac D; Gasparini P; Kanavakis E; Claustres M; Kambouris M; Ostrer H; Duff G; Baranov V; Sibul H; Metspalu A; Goldman D; Martin N; Duffy D; Schmidtke J; Estivill X; O'Brien SJ; Dean M
    Am J Hum Genet; 1998 Jun; 62(6):1507-15. PubMed ID: 9585595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of the CCR5 beta-chemokine receptor and inhibition of HIV-1 infection by stable VA1-ribozyme chimeric transcripts.
    Cagnon L; Rossi JJ
    Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):251-61. PubMed ID: 10984119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A strong signature of balancing selection in the 5' cis-regulatory region of CCR5.
    Bamshad MJ; Mummidi S; Gonzalez E; Ahuja SS; Dunn DM; Watkins WS; Wooding S; Stone AC; Jorde LB; Weiss RB; Ahuja SK
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10539-44. PubMed ID: 12149450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased susceptibility of peripheral blood mononuclear cells from individuals heterozygous for a mutant CCR5 allele to HIV infection.
    Kim A; Pettoello-Mantovani M; Goldstein H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):145-9. PubMed ID: 9768623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of the CCR 5 gene in seronegative individuals exposed to human immunodeficiency virus (HIV).
    Rugeles MT; Solano F; Díaz FJ; Bedoya VI; Patiño PJ
    J Clin Virol; 2002 Jan; 23(3):161-9. PubMed ID: 11595595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of CCR5 delta 32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infection.
    Sei S; Boler AM; Nguyen GT; Stewart SK; Yang QE; Edgerly M; Wood LV; Brouwers P; Venzon DJ
    AIDS; 2001 Jul; 15(11):1343-52. PubMed ID: 11504955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region.
    Platt EJ; Kuhmann SE; Rose PP; Kabat D
    J Virol; 2001 Dec; 75(24):12266-78. PubMed ID: 11711617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First report of a healthy Indian heterozygous for delta 32 mutant of HIV-1 co-receptor-CCR5 gene.
    Husain S; Goila R; Shahi S; Banerjea A
    Gene; 1998 Jan; 207(2):141-7. PubMed ID: 9511755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of the CCR5 gene 32-bp deletion in Europe.
    Lucotte G; Mercier G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):174-7. PubMed ID: 9768627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variants of human immunodeficiency virus type 1 that efficiently use CCR5 lacking the tyrosine-sulfated amino terminus have adaptive mutations in gp120, including loss of a functional N-glycan.
    Platt EJ; Shea DM; Rose PP; Kabat D
    J Virol; 2005 Apr; 79(7):4357-68. PubMed ID: 15767436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The first report of CCR5 delta 32 mutant in Thai injecting drug users.
    Ruchusatsawat N; Vongsheree S; Thaisri H; Phutiprawan T
    Asian Pac J Allergy Immunol; 2000 Jun; 18(2):93-8. PubMed ID: 10928621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequencies of SDF-1 chemokine, CCR-5, and CCR-2 chemokine receptor gene alleles conferring resistance to human immunodeficiency virus type 1 and AIDS in Kuwaitis.
    Voevodin A; Samilchuk E; Dashti S
    J Med Virol; 1999 May; 58(1):54-8. PubMed ID: 10223546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.
    Kostrikis LG; Huang Y; Moore JP; Wolinsky SM; Zhang L; Guo Y; Deutsch L; Phair J; Neumann AU; Ho DD
    Nat Med; 1998 Mar; 4(3):350-3. PubMed ID: 9500612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical and HIV-1 coreceptor properties of K26R, a new CCR5 Variant in China's Sichuan population.
    Ma L; Dudoit Y; Tran T; Xing H; Chen J; Pancino G; Bismuth G; Debré P; Shao Y; Theodorou I; Capoulade-Métay C
    J Acquir Immune Defic Syndr; 2005 May; 39(1):38-43. PubMed ID: 15851912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.